# CereVasc opens new manufacturing and R&D facility in Wilmington, Massachusetts

CereVasc opened a new manufacturing and research facility in Wilmington, Massachusetts, including an ISO Class 7 clean room, to support potential commercialisation of the eShunt System after completing STRIDE trial enrollment and an $85 million Series C financing.

- Type: New facility
- Announced: 2026-07-30
- Where: Wilmington, Massachusetts, United States
- Starts operating: 30 Jul 2026
- Status: completed
- Products: eShunt System, minimally invasive neurological devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CereVasc](https://endata.com/companies/93245.md)

## Sources

- [cerevasc.com](https://cerevasc.com/cerevasc-opens-new-massachusetts-facility-in-preparation-for-eshunt-system-commercialization/), 2026-07-30: "This facility is an investment in CereVasc's future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.